Table 6.
B | 95% CI | p value | |
---|---|---|---|
FVC as dependent variable | |||
Male gender | −11.0 | −19.2 to −2.9 | 0.008 |
Interstitial findings on HRCT | −14.8 | −21.1 to −8.4 | < 0.001 |
ACA positivity | 7.2 | 0.1 to 14.3 | 0.045 |
Neoangiogenesis/mm | −7.3 | −11.0 to −3.6 | < 0.001 |
DLCO as dependent variable | |||
Digital ulcers | −6.7 | −13.6 to 0.1 | 0.056 |
Interstitial findings on HRCT | −9.4 | −16.4 to −2.5 | 0.008 |
FVC | 0.5 | 0.3 to 0.7 | <0.001 |
PAH confirmed by RHC | −14.3 | −26.9 to −1.6 | 0.027 |
TRV ≥ 2.9 m/s or other echo PH signs | −16.4 | − 28.3 to −4.6 | 0.007 |
Enlarged capillaries | 7.8 | 1.1 to 14.4 | 0.021 |
Giant capillaries | −11.8 | −21.4 to −2.2 | 0.016 |
Only variables with statistical significance or tendency to be significant are presented
B regression coefficient, CI confidence interval, FVC forced vital capacity, HRCT high resolution computed tomography, ACA anticentromere antibodies, DLCO diffusion capacity of the lung for carbon monoxide, PAH pulmonary arterial hypertension, RHC right heart catheterization, TRV tricuspid regurgitation velocity, PH pulmonary hypertension